GSK in the United States seeks a Medical leadership role in safety evaluation and risk management for oncology assets in clinical development. Responsible for interpreting safety data, escalating signals, and delivering evidence-based recommendations to support benefit-risk decisions.
This role contributes to global governance and protects patient safety across innovative oncology medicines. This hybrid role is based in the United States, with on-site governance meetings and remote work support.
#J-18808-Ljbffr
This opportunity is for the Hybrid Oncology Safety Director (SERM) role at Women In Bio.
This role, Hybrid Oncology Safety Director (SERM) at Women In Bio, could be your next opportunity.
Are you ready to take on the Hybrid Oncology Safety Director (SERM) role at Women In Bio?
We would love to welcome a new Hybrid Oncology Safety Director (SERM) to our group in Collegeville, PA, United States.